Related Experiment Videos
Chronic hepatitis B. Hope for decreasing its impact
1Department of Internal Medicine, Saint Louis University Health Sciences Center, MO 63104, USA.
Postgraduate Medicine
|July 1, 1995
Summary
Chronic hepatitis B treatment shows promise with alpha interferon therapy, benefiting up to one-third of eligible patients. Hepatitis B prevention through widespread vaccination offers a path to potentially eliminate this common viral infection.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic hepatitis B is a prevalent disease with potentially severe outcomes.
- The prognosis for chronic hepatitis B is not uniformly poor, indicating potential for therapeutic intervention.
Purpose of the Study:
- To review the current therapeutic options for chronic hepatitis B.
- To discuss the potential of new drug development for hepatitis B.
- To highlight the role of hepatitis B vaccination in disease prevention.
Main Methods:
- Review of existing literature on hepatitis B treatments.
- Analysis of the efficacy of alpha interferon therapy.
- Discussion of emerging therapeutic agents and vaccination strategies.
Main Results:
- Alpha interferon therapy is effective in approximately one-third of patients with hepatitis B e antigen and elevated aminotransferase levels.
- New therapeutic drugs are under development with the potential for improved outcomes.
- Hepatitis B vaccination is a key preventive measure.
Conclusions:
- While chronic hepatitis B can be serious, treatment options like alpha interferon offer benefits.
- Ongoing drug development and widespread vaccination are crucial for managing and potentially eradicating hepatitis B.
- National vaccination programs hold the potential to significantly decrease the impact of this viral infection.